0001209191-18-010969.txt : 20180216
0001209191-18-010969.hdr.sgml : 20180216
20180216180502
ACCESSION NUMBER: 0001209191-18-010969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180215
FILED AS OF DATE: 20180216
DATE AS OF CHANGE: 20180216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pope Todd
CENTRAL INDEX KEY: 0001584367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 18622470
MAIL ADDRESS:
STREET 1: C/O TRANSENTERIX
STREET 2: 635 DAVIS DRIVE, SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-15
0
0000876378
TRANSENTERIX INC.
TRXC
0001584367
Pope Todd
C/O TRANSENTERIX, INC.
635 DAVIS DRIVE, SUITE 300
MORRISVILLE
NC
27560
1
1
0
0
President and CEO
Stock Options
0.00
2018-02-15
4
J
0
403000
0.00
D
2028-02-07
Common Stock
403000
1000000
D
Restricted Stock Units
0.00
2018-02-15
4
A
0
268667
0.00
A
Common Stock
268667
268667
D
A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect.
Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan.
Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the restricted stock units in three annual installments of one-third of the award (89,555, 89,556 and 89,556) on each of February 4, 2019, 2020 and 2021, respectively, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan.
/s/ Joshua Weingard,as Attorney-in-Fact for Todd Pope
2018-02-16